CONVERSION AND AMENDMENT AGREEMENT
Exhibit 4.14
CONVERSION AND AMENDMENT AGREEMENT
THIS CONVERSION AND AMENDMENT AGREEMENT (this Agreement) is made and entered into as of June 16, 2011, by and among HORIZON PHARMA, INC., a Delaware corporation (the Company), and the undersigned stockholders of the Company (the Stockholders).
RECITALS
WHEREAS, the Company is contemplating the consummation of a firm commitment underwritten initial public offering of its common stock (the IPO);
WHEREAS, the Stockholders are holders of shares of the Companys outstanding Series A Preferred Stock (the Series A Preferred) and Series B Preferred Stock (the Series B Preferred, together with the Series A Preferred, the Series Preferred), and/or shares of the Companys Common Stock (Common Stock);
WHEREAS, pursuant to the Companys Amended and Restated Certificate of Incorporation, as amended and as may be amended from time to time (the Restated Certificate), each share of Series Preferred shall automatically be converted into shares of Common Stock, based on the then-effective Conversion Price (as defined in the Restated Certificate) applicable to such share of Series Preferred, immediately upon the earlier of (A) the Companys sale of its Common Stock in a firm commitment underwritten public offering pursuant to a registration statement under the Securities Act of 1933, as amended, provided: (i) such offering results in aggregate gross cash proceeds of not less than $50,000,000 (prior to underwriting discounts and commissions) and (ii) the shares of Common Stock so sold are listed on the NYSE, the NASDAQ Global Select Market, or the NASDAQ Global Market (a Qualified IPO); or (B) the date specified by written consent or agreement of the holders of at least 66 2/3% of the then outstanding shares of Series Preferred, voting together as a single class on an as-converted basis;
WHEREAS, the Stockholders constitute the holders of at least 66 2/3% of the outstanding shares of the Series Preferred, voting together as a single class on an as-converted basis;
WHEREAS, the Company and certain of the undersigned Stockholders, among others, are parties to that certain Investors Rights Agreement dated as of April 1, 2010 (the Investors Rights Agreement) and that certain Voting Agreement dated as of April 1, 2010 (the Voting Agreement);
WHEREAS, the Investors Rights Agreement contains certain provisions the termination of which are triggered by the closing of a Qualified IPO;
WHEREAS, the Voting Agreement terminates upon the consummation of a firm commitment underwritten public offering by the Company of shares of its Common Stock in connection with which all of the outstanding shares of Series Preferred are converted into shares of Common Stock, pursuant to the Restated Certificate;
1.
WHEREAS, any term of the Investors Rights Agreement may be amended or waived with the written consent of the Company and the holders of at least 66 2/3% of the Registrable Securities (as defined in the Investors Rights Agreement) then outstanding;
WHEREAS, the undersigned stockholders have the requisite percentages of the applicable securities required to amend the provisions of the Investors Rights Agreement;
WHEREAS, the undersigned Stockholders desire to assist the Company in proceeding with an IPO and, in connection therewith, desire to amend certain provisions of the Investors Rights Agreement and to confirm the termination of the Voting Agreement; and
WHEREAS, in order to eliminate any uncertainty or delay with respect to the conversion of the Series Preferred in connection with the IPO the undersigned Stockholders desire to: (A) approve the conversion, effective immediately prior to the closing of the IPO, of each share of Series Preferred then outstanding into Common Stock at the then-effective applicable Conversion Price, provided that the price per share of the Common Stock sold in the IPO to the public is approved by the Board of Directors of the Company (the Board) or the Pricing Committee of the Board (an Approved IPO), and (B) amend the Investors Rights Agreement and confirm the termination of the Voting Agreement, all as more fully set forth herein.
AGREEMENT
NOW, THEREFORE, the parties to this Agreement, for good and valuable consideration, the receipt and sufficiency of which are acknowledged and agreed, hereby agree as follows:
1. CONVERSION. Each undersigned Stockholder, with respect to all shares of Series Preferred held by it, hereby agrees and consents that, effective immediately prior to the closing of an Approved IPO, whether or not such Approved IPO also constitutes a Qualified IPO, all outstanding shares of the Series Preferred shall automatically be converted into shares of Common Stock at the applicable Conversion Price (each as defined in the Restated Certificate) then in effect.
2. AMENDMENT OF INVESTORS RIGHTS AGREEMENT. The Company and the undersigned Stockholders that are holders of Registrable Securities, with respect to all shares of Registrable Securities held thereby, on behalf of themselves and all other holders of Registrable Securities, hereby amend the Investors Rights Agreement as follows:
The following defined term in Section 1.1(i) of the Investors Rights Agreement is hereby amended in its entirety as follows:
Qualified IPO means the Companys sale of its Common Stock in a firm commitment underwritten public offering pursuant to a registration statement under the Securities Act, provided: (i) the price per share of the Common Stock sold in the IPO to the public is approved by the Board or a Pricing Committee of the Board and (ii) the shares of Common Stock so sold are listed on the NYSE, the NASDAQ Global Select Market, or the NASDAQ Global Market.
2.
3. TERMINATION OF VOTING AGREEMENT. The Company and the undersigned Stockholders, on behalf of themselves and all other parties to the Voting Agreement, hereby acknowledge that, effective immediately prior to the closing of an Approved IPO, the Voting Agreement shall terminate in its entirety and be of no further force or effect pursuant to its terms.
4. SUNSET. Notwithstanding anything to the contrary set forth herein, this Agreement and all obligations hereunder shall terminate and this Agreement shall have no force or effect retrospectively or prospectively if the closing of an Approved IPO has not occurred prior to September 30, 2011.
5. MISCELLANEOUS.
(a) Entire Agreement; Binding Effect. This Agreement constitutes the entire agreement of the parties hereto related to the matters set forth herein, and supersedes all prior agreements between such parties, whether written or oral, related to such subject matter. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties hereto. Except as amended or expressly provided hereby, the terms of the Investors Rights Agreement and the Voting Agreement shall remain in full force and effect.
(b) Amendment; Waiver. Neither this Agreement nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument signed by the Company and each party against whom enforcement of such amendment, waiver, discharge or termination is sought.
(c) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of California as applied to contracts among California residents entered into and performed entirely within California.
(d) Counterparts; Facsimile. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Facsimile signatures shall be as effective as original signatures.
(e) Further Assurances. Each party hereto agrees to execute and deliver, or cause to be executed and delivered, such further instruments or documents or take such other actions as may be reasonably necessary to consummate the transactions contemplated by this Agreement.
3.
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
COMPANY: | ||
HORIZON PHARMA, INC. | ||
By: | /s/ Timothy P. Walbert | |
Name: | Timothy P. Walbert | |
Title: | Chairman, President and | |
Chief Executive Officer |
[SIGNATURE PAGE TO CONVERSION AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDER: | ||
SCALE VENTURE PARTNERS II, L.P. | ||
By: | Scale Venture Management II, LLC | |
Its: | General Partner |
/s/ Lou Bock |
Lou Bock |
Managing Director |
[SIGNATURE PAGE TO CONVERSION AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDERS: | ||
SUTTER HILL VENTURES, A CALIFORNIA LIMITED PARTNERSHIP | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | Jeffrey W. Bird | |
Managing Director of the General Partner | ||
JEFFREY W. BIRD AND CHRISTINA R. BIRD AS TRUSTEES OF JEFFREY W. AND CHRISTINA R. BIRD TRUST AGREEMENT DATED 10/31/00 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Jeffrey W. Bird, Trustee |
[SIGNATURE PAGE TO CONVERSION AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDER S: | ||
ESSEX WOODLANDS HEALTH VENTURES FUND VII, L.P. | ||
By: | Essex Woodlands Health Ventures VII, LP. | |
Its: | General Partner | |
By: | Essex Woodlands Health Ventures VII, L.L.C. | |
Its: | General Partner | |
By: | /s/ Jeff Himawan | |
Jeff Himawan, Managing Director |
[SIGNATURE PAGE TO CONVERSION AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDER S:
ATLAS VENTURE FUND VI, L.P. | ||
By: | Atlas Venture Associates VI, L.P. | |
Their: | General Partner | |
By: | Atlas Venture Associates VI, Inc. | |
Its: | General Partner | |
By: | /s/ Kristen Laguerre | |
Name: | Kristen Laguerre | |
Title: | Vice President | |
ATLAS VENTURE ENTREPRENEURS FUND VI, L.P. | ||
By: | Atlas Venture Associates VI, L.P. | |
Their: | General Partner | |
By: | Atlas Venture Associates VI, Inc. | |
Its: | General Partner | |
By: | /s/ Kristen Laguerre | |
Name: | Kristen Laguerre | |
Title: | Vice President | |
ATLAS VENTURE FUND VI GMBH & CO. KG | ||
By: | Atlas Venture Associates VI, L.P. | |
Its: | Managing Limited Partner | |
By: | Atlas Venture Associates VI, Inc. | |
Its: | General Partner | |
By: | /s/ Kristen Laguerre | |
Name: | Kristen Laguerre | |
Title: | Vice President |
[SIGNATURE PAGE TO CONVERSION AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDER S:
THE GLOBAL LIFE SCIENCE VENTURES FONDS II GMBH & CO KG | ||
By: | The Global Life Science Ventures GmbH | |
Its: | General Partner | |
By: | /s/ Dr. Hans A. Kupper | |
Name: | Dr. Hans A. Kupper | |
Title: | Managing Director of the GLSV GmbH | |
the General Partner of the GLSV Fond II GmbH + CoKG | ||
THE GLOBAL LIFE SCIENCE VENTURES FUND II LIMITED PARTNERSHIP | ||
By: | Global Life Science Ventures (GP) Limited | |
Its: | General Partner | |
By: | /s/ Barry McClay | |
Name: | Barry McClay | |
Title: | Director |
[SIGNATURE PAGE TO CONVERSION AND AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDER S:
NGN BIOMED OPPORTUNITY I, L.P. | ||
By: | NGN BioMed I, G.P., L.P. | |
Its: | General Partner | |
By: | NGN Capital LLC | |
Its: | General Partner | |
By: | /s/ Peter Johann | |
Name: | Dr. Peter Johann | |
Title: | Managing General Partner | |
NGN BIOMED OPPORTUNITY I GMBH & CO. BETEILIGUNGS KG | ||
By: | NGN Capital LLC | |
Its: | Managing Limited Partner | |
By: | /s/ Peter Johann | |
Name: | Dr. Peter Johann | |
Title: | Managing General Partner |
[SIGNATURE PAGE TO CONVERSION AND AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDER:
TVM LIFE SCIENCE VENTURES VI, L.P. | ||
By: | TVM Life Science Ventures VI Cayman Ltd., | |
Its | General Partner | |
By: | /s/ Mark Cipriano | |
Name: | Mark Cipriano | |
Title: | Authorized Officer | |
By: | /s/ John J. Dierko | |
Name: | John J. Dierko | |
Title: | Authorized Officer | |
TVM LIFE SCIENCE VENTURES VI GMBH & CO. KG | ||
By: | /s/ Mark Cipriano | |
Name: | Mark Cipriano | |
Title: | Managing Limited Partner | |
By: | /s/ John J. Dierko | |
Name: | John J. Dierko | |
Title: | Managing Limited Partner |
[SIGNATURE PAGE TO CONVERSION AND AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDERS:
CD-VENTURE GMBH | ||
By: | /s/ Christian Boehringer | |
Name: | Christian Boehringer | |
Title: | General Manager and Owner | |
ANMA VENTURE GMBH | ||
By: | /s/ Mathias Boehringer | |
Name: | Dr. Mathias Boehringer | |
Title: | Managing Director | |
CBI GMBH | ||
By: | /s/ Christian Boehringer | |
Name: | Christian Boehringer | |
Title: | Managing Director |
[SIGNATURE PAGE TO CONVERSION AND AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDERS: | ||
DAVID L. ANDERSON, TRUSTEE OF THE ANDERSON LIVING TRUST U/A/D 1/22/98 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: |
ANVEST, L.P. | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: |
G. LEONARD BAKER, JR. AND MARY ANNE BAKER, CO-TRUSTEES OF THE BAKER REVOCABLE TRUST, U/A/D 2/3/03 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: |
TENCH COXE AND SIMONE OTUS COXE, CO-TRUSTEES OF THE COXE REVOCABLE TRUST, U/A/D 4/23/98 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: |
DAVID E. SWEET AND ROBIN T. SWEET, AS TRUSTEES OF THE DAVID & ROBIN SWEET LIVING TRUST, DATED 7/6/04 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: |
[SIGNATURE PAGE TO CONVERSION AND AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDERS: | ||
JAMES C. GAITHER, TRUSTEE OF THE GAITHER REVOCABLE TRUST, U/A/D 9/28/00 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: |
/s/ Robert Yin, Under Power of Attorney |
JAMES C. GAITHER |
/s/ Robert Yin, Under Power of Attorney |
LYNN B. GRAW |
/s/ Robert Yin, Under Power of Attorney |
PATRICIA TOM |
/s/ Robert Yin, Under Power of Attorney |
JULIE A. YOUNGER |
/s/ Robert Yin, Under Power of Attorney |
KELLY L. YOUNGER |
/s/ Robert Yin, Under Power of Attorney |
MARK YOUNGER |
[SIGNATURE PAGE TO CONVERSION AND AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDERS: | ||
ROOSTER PARTNERS, LP | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: |
SAUNDERS HOLDINGS, L.P. | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: |
TALLACK PARTNERS, L.P. | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: |
PATRICK AND YING CHEN 2001 LIVING TRUST DATED 3/17/01 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: |
JAMES N. WHITE AND PATRICIA A. OBRIEN, AS TRUSTEES OF THE WHITE FAMILY TRUST, U/A/D 4/3/97 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: |
[SIGNATURE PAGE TO CONVERSION AND AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDERS: | ||
YIN FAMILY TRUST DATED MARCH 1, 1997 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: | ||
NAAR FAMILY TRUST U/A/D 12/22/94 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: | ||
GREGORY P. SANDS AND SARAH J.D. SANDS, AS TRUSTEES (SANDS 2/24/99 TRUST) | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: | ||
JAMES N WHITE, TRUSTEE OF SIERRA TRUST U/A/D 12/16/1997 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: | ||
SHERRYL WILEY CASELLA, TRUSTEE OF SHERRYL WILEY CASELLA REVOCABLE TRUST DATED 5/8/06 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: |
[SIGNATURE PAGE TO CONVERSION AND AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDERS: | ||
STEVEN J. GRAW AND LYNNE B. GRAW AS TRUSTEES OF THE GRAW FAMILY TRUST U/A/D 2/20/08 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: | ||
JAMES G LAPLANTE JR, MARK W YOUNGER, DAVIDE E. SWEET, CO-TRUSTEES OF LAUREN YOUNGER LIVING TRUST U/A/D 7/30/09 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: | ||
WILLIAM H. YOUNGER, JR. REVOCABLE TRUST U/A/D 8/5/2009 | ||
By: | /s/ Robert Yin, Under Power of Attorney | |
Name: | ||
Title: |
[SIGNATURE PAGE TO CONVERSION AND AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDERS: | ||
Wells Fargo Bank, N.A., Trustee Attention: Thomas M. Thurston 600 California Street 12th Floor MAC A0193-120 San Francisco, CA. 94108 Phone: (415)  ###-###-#### Fax: (415)  ###-###-#### Email: ***@*** | ||
WELLS FARGO BANK, N.A. FBO SHV PROFIT SHARING PLAN FBO SHERYLL W. CASELLA | ||
By: | /s/ Thomas M. Thurston | |
WELLS FARGO BANK, N.A. FBO SHV PROFIT SHARING PLAN FBO WILLIAM H. YOUNGER, JR. | ||
By: | /s/ Thomas M. Thurston | |
WELLS FARGO BANK, N.A. FBO SHV PROFIT SHARING PLAN FBO TENCH COXE | ||
By: | /s/ Thomas M. Thurston | |
WELLS FARGO BANK, N.A. FBO SHV PROFIT SHARING PLAN FBO DAVID E. SWEET (ROLLOVER) | ||
By: | /s/ Thomas M. Thurston | |
WELLS FARGO BANK, N.A. FBO SHV PROFIT SHARING PLAN FBO G. LEONARD BAKER, JR. | ||
By: | /s/ Thomas M. Thurston |
[SIGNATURE PAGE TO CONVERSION AND AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDERS: | ||
WELLS FARGO BANK, N.A. FBO SHV PROFIT SHARING PLAN FBO DIANE J. NAAR | ||
By: | /s/ Thomas M. Thurston | |
WELLS FARGO BANK, N.A. FBO SHV PROFIT SHARING PLAN FBO YU-YING CHEN | ||
By: | /s/ Thomas M. Thurston | |
WELLS FARGO BANK, N.A. FBO SHV PROFIT SHARING PLAN FBO PATRICIA TOM (PRE) | ||
By: | /s/ Thomas M. Thurston | |
WELLS FARGO BANK, N.A. FBO SHV PROFIT SHARING PLAN FBO ROBERT YIN | ||
By: | /s/ Thomas M. Thurston | |
WELLS FARGO BANK, N.A. FBO SHV PROFIT SHARING PLAN FBO LYNNE B. GRAW | ||
By: | /s/ Thomas M. Thurston | |
WELLS FARGO BANK, N.A. FBO SHV PROFIT SHARING PLAN FBO LYNNE B. GRAW (ROLLOVER) | ||
By: | /s/ Thomas M. Thurston |
[SIGNATURE PAGE TO CONVERSION AND AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDERS: | ||
WELLS FARGO BANK, N.A. FBO SHV PROFIT SHARING PLAN FBO PATRICIA TOM (POST) | ||
By: | /s/ Thomas M. Thurston | |
WELLS FARGO BANK, N.A. FBO SHV PROFIT SHARING PLAN FBO LAUREN YOUNGER | ||
By: | /s/ Thomas M. Thurston | |
[SIGNATURE PAGE TO CONVERSION AND AMENDMENT AGREEMENT]
IN WITNESS WHEREOF, the parties hereto have executed this CONVERSION AND AMENDMENT AGREEMENT as of the date first written above.
STOCKHOLDERS: |
/s/ Barry Golombik |
BARRY GOLOMBIK |
BARRY L. GOLOMBIK AND MARY CATHERINE DANAHEY, CO-TRUSTEES OF THE GOLOMBIK / DANAHEY FAMILY TRUST 1998 | ||
By: | /s/ Barry Golombik | |
Name: | Barry Golombik | |
Title: | Trustee |
[SIGNATURE PAGE TO CONVERSION AND AMENDMENT AGREEMENT]